• Issue

    British Journal of Haematology: Volume 162, Issue 4

    429-569
    August 2013
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Editorial Comment

Readying the minimal residual disease concept in acute myeloid leukaemia for prime time – the American way

Peter Hokland,  Finbarr Cotter, 
  • Pages: 429-430
  • First Published: 15 June 2013

Images in Haematology

Pepperpot or not?

Caroline M. Harvey,  Rebecca G. Gallagher,  Karen J. Fairbairn,  Jennifer L. Byrne, 
  • Page: 431
  • First Published: 15 June 2013

Metastatic malignant melanoma detected on bone marrow aspiration

Diego Velasco-Rodríguez,  María Castellanos-González,  Juan Manuel Alonso-Domínguez,  Manuel Martín-González,  Jesús Villarrubia, 
  • Page: 432
  • First Published: 24 June 2013

Reviews

Coagulation and metastasis: what does the experimental literature tell us?

Ana M. Gil-Bernabé,  Serena Lucotti,  Ruth J. Muschel, 
  • Pages: 433-441
  • First Published: 21 May 2013

Update on the use of pathogen-reduced human plasma and platelet concentrates

Axel Seltsam,  Thomas H. Müller, 
  • Pages: 442-454
  • First Published: 27 May 2013

Sickle cell disease: time for a closer look at treatment options?

Sujit Sheth,  Maureen Licursi,  Monica Bhatia, 
  • Pages: 455-464
  • First Published: 15 June 2013

Haematological Malignancy

Prognostic impact of monocyte count at presentation in mantle cell lymphoma

Kathrin Aprile von Hohenstaufen,  Annarita Conconi,  Cassio Polpo de Campos,  Silvia Franceschetti,  Francesco Bertoni,  Gloria Margiotta Casaluci,  Anastasios Stathis,  Michele Ghielmini,  Georg Stussi,  Franco Cavalli,  Gianluca Gaidano,  Emanuele Zucca, 
  • Pages: 465-473
  • First Published: 29 June 2013

Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients

Teresa Caballero-Velázquez,  Lucia López-Corral,  Cristina Encinas,  Cristina Castilla-Llorente,  Rodrigo Martino,  Laura Rosiñol,  Antonia Sampol,  Dolores Caballero,  David Serrano,  Inmaculada Heras,  Jesús San Miguel,  José A. Pérez-Simón, 
  • Pages: 474-482
  • First Published: 15 June 2013

Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents

Christine I. Chen,  Esther Masih-Khan,  Haiyan Jiang,  Ahmed Rabea,  Christine Cserti-Gazdewich,  Victor H. Jimenez-Zepeda,  Chia-Min Chu,  Vishal Kukreti,  Suzanne Trudel,  Rodger Tiedemann,  Richard Tsang,  Donna E. Reece, 
  • Pages: 483-488
  • First Published: 15 June 2013

Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique

Michael Darmon,  François Vincent,  Laurent Camous,  Emmanuel Canet,  Caroline Bonmati,  Thorsten Braun,  Denis Caillot,  Jérôme Cornillon,  Sophie Dimicoli,  Anne Etienne,  Lionel Galicier,  Alice Garnier,  Stéphane Girault,  Mathilde Hunault-Berger,  Jean-Pierre Marolleau,  Philippe Moreau,  Emmanuel Raffoux,  Christian Recher,  Anne Thiebaud,  Catherine Thieblemont,  Elie Azoulay, on behalf of the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique (GRRR-OH) , 
  • Pages: 489-497
  • First Published: 15 June 2013

A phase II study of vorinostat (MK-0683) in patients with polycythaemia vera and essential thrombocythaemia

Christen L. Andersen,  Mary F. McMullin,  Elisabeth Ejerblad,  Sonja Zweegman,  Claire Harrison,  Savio Fernandes,  David Bareford,  Steven Knapper,  Jan Samuelsson,  Eva Löfvenberg,  Olle Linder,  Bjørn Andreasson,  Erik Ahlstrand,  Morten K. Jensen,  Ole W. Bjerrum,  Hanne Vestergaard,  Herdis Larsen,  Tobias W. Klausen,  Torben Mourits-Andersen,  Hans C. Hasselbalch, 
  • Pages: 498-508
  • First Published: 11 June 2013

Survival and cure of acute myeloid leukaemia in England, 1971-2006: a population–based study

Anjali Shah,  Therese M.-L. Andersson,  Bernard Rachet,  Magnus Björkholm,  Paul C. Lambert, 
  • Pages: 509-516
  • First Published: 21 June 2013

Phase I clinical trial of oral rigosertib in patients with myelodysplastic syndromes

Rami S. Komrokji,  Azra Raza,  Jeffrey E. Lancet,  Chen Ren,  David Taft,  Manoj Maniar,  Francois Wilhelm,  Alan F. List, 
  • Pages: 517-524
  • First Published: 21 June 2013

Long-term survival with low toxicity after allogeneic transplantation for acute myeloid leukaemia and myelodysplasia using non-myeloablative conditioning without T cell depletion

Jeff K. Davies,  David Taussig,  Heather Oakervee,  Matthew Smith,  Samir Agrawal,  Jamie D. Cavenagh,  John G. Gribben, 
  • Pages: 525-529
  • First Published: 29 May 2013

Paediatrics

Target enrichment and high-throughput sequencing of 80 ribosomal protein genes to identify mutations associated with Diamond-Blackfan anaemia

Gareth Gerrard,  Mikel Valgañón,  Hui En Foong,  Dalia Kasperaviciute,  Deena Iskander,  Laurence Game,  Michael Müller,  Timothy J. Aitman,  Irene Roberts,  Josu de la Fuente,  Letizia Foroni,  Anastasios Karadimitris, 
  • Pages: 530-536
  • First Published: 30 May 2013

Hypomethylation of the CTGF gene locus is a common feature of paediatric pre-B acute lymphoblastic leukaemia

Mathew D. Welch,  Wayne K. Greene,  Ursula R. Kees, 
  • Pages: 537-541
  • First Published: 15 June 2013

Red Cells and Iron

Genetic regulation of fetal haemoglobin in inherited bone marrow failure syndromes

Blanche P. Alter,  Philip S. Rosenberg,  Thomas Day,  Stephan Menzel,  Neelam Giri,  Sharon A. Savage,  Swee Lay Thein, 
  • Pages: 542-546
  • First Published: 29 May 2013

Correspondence

Free Access

The treatment of recurrent epistaxis due to hereditary haemorrhagic telangiectasia with intranasal bevacizumab

Charles Alderman,  Jonathan Corlett,  Jonathan Cullis, 
  • Pages: 547-548
  • First Published: 14 May 2013
Free Access

Ponatinib in patients with refractory acute myeloid leukaemia: findings from a phase 1 study

Neil P. Shah,  Moshe Talpaz,  Michael W. N. Deininger,  Michael J. Mauro,  Ian W. Flinn,  Dale Bixby,  Stephanie Lustgarten,  Joseph M. Gozgit,  Tim Clackson,  Christopher D. Turner,  Frank G. Haluska,  Hagop Kantarjian,  Jorge E. Cortes, 
  • Pages: 548-552
  • First Published: 21 May 2013
Free Access

Cyclosporin combined with levamisole for refractory or relapsed severe aplastic anaemia

Yingqi Shao,  Xingxin Li,  Jun Shi,  Meili Ge,  Jinbo Huang,  Zhendong Huang,  Jing Zhang,  Neng Nie,  Yizhou Zheng, 
  • Pages: 552-555
  • First Published: 23 May 2013
Free Access

Correlation between burden of 17P13.1 alteration and rapid escape to plasma cell leukaemia in multiple myeloma

Silvia Mangiacavalli,  Lara Pochintesta,  Federica Cocito,  Alessandra Pompa,  Paolo Bernasconi,  Mario Cazzola,  Alessandro Corso, 
  • Pages: 555-558
  • First Published: 30 May 2013
Free Access

Use of eculizumab in the treatment of a case of refractory, ADAMTS13-deficient thrombotic thrombocytopenic purpura: additional data and clinical follow-up

Eugenia Tsai,  John Chapin,  Jeffrey C. Laurence,  Han-Mou Tsai, 
  • Pages: 558-559
  • First Published: 21 May 2013
Free Access

Histone deacetylase (HDAC) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDAC

Sridurga Mithraprabhu,  Tiffany Khong,  Simon S. Jones,  Andrew Spencer, 
  • Pages: 559-562
  • First Published: 21 May 2013
Free Access

Implication of MAPK1/MAPK3 signalling pathway in t(8;9)(p22;24)/PCM1-JAK2 myelodysplastic/myeloproliferative neoplasms

Elena Masselli,  Cristina Mecucci,  Giuliana Gobbi,  Cecilia Carubbi,  Valentina Pierini,  Gabriella Sammarelli,  Sabrina Bonomini,  Lucia Prezioso,  Elena Rossetti,  Cecilia Caramatti,  Franco Aversa,  Marco Vitale, 
  • Pages: 563-566
  • First Published: 24 May 2013
Free Access

Genome-wide high resolution DNA profiling of hairy cell leukaemia

Andrea Rinaldi,  Ivo Kwee,  Ken H. Young,  Emanuele Zucca,  Gianluca Gaidano,  Francesco Forconi,  Francesco Bertoni, 
  • Pages: 566-569
  • First Published: 21 May 2013